2 Years Part Time
This Masters provides graduates with exemplary career opportunities in both the pharmaceutical and biopharmaceutical industry. This programme provides substantial coverage of scientific, technical, management and regulatory issues associated with these industries, providing an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology.
UCD is highly attractive to students due to the exposure to world leading
researchers and the significant career prospects.
The Programme's teaching methods are highly interactive and varied. Students participate in lectures, workshops, tutorials and practical exercises.
The course content addresses the principle scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities. Case-studies of US and UK biotech firms, described by senior company executives, are used to illustrate the possibilities and limitations of commercial exploitation of scientific discoveries.
The programme consists of 12 modules with core modules in Biopharmaceutical Engineering, option engineering modules for Science graduates and option biology modules for Engineering graduates and a research project. Overall, 90 ‘credits’ must be achieved to complete the programme: each of the 12 modules account for 5 ‘credits’ each, and the project accounts for 30 ‘credits’.
Classes take place every Friday afternoon (during UCD term time) between 14.00 - 18.00 at the NIBRT facility, Belfield Campus, UCD.
4 year bachelor’s degree with a minimum upper second class honours (NFQ level 8) or international equivalence in a relevant Engineering, Science or Technology programme